GSK lifts long-term sales targets on new drug pipeline
It came as the boss of the London-listed firm cheered an ‘excellent’ performance in 2024.

Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Mar 26, 2025 0
Or register with email
Jan 28, 2025 0
Jan 26, 2025 0
Mar 1, 2025 0
Feb 24, 2025 0
Feb 14, 2025 0
Jan 30, 2025 1
Jan 29, 2025 0
Jan 28, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.